Feature Channels: Vaccines

• share
• favorite_border

Radames and Ana Arocho were all smiles when they arrived on the white school bus, and their enthusiasm was contagious.

• share
• favorite_border

As older teens and young adults become eligible for COVID-19 vaccination across the country, and younger teens await their turn, new survey data suggest a strong readiness that has grown since fall. But just as with older generations, a shrinking but still sizable minority of people age 14 to 24 say they’re not willing to get vaccinated, or that their decision will depend on safety.

• share
• favorite_border

A slightly lighthearted guide to post-vaccination life, including how to help others who haven't gotten vaccinated yet.

• share
• favorite_border

Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine.

• share
• favorite_border

• share
• favorite_border

What can vaccine proponents, clinicians and public health communicators learn from “anti-vaxxers?” A lot, according to new guidance for pro-vaccination social media events written by University of Pittsburgh health scientists.

• share
• favorite_border

Nationwide, the rollout for the COVID-19 vaccine has been inequitable, with white individuals being vaccinated at higher rates compared to Black individuals.

• share
• favorite_border

• share
• favorite_border

A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15.

• share
• favorite_border

New research has for the first time compared images of the protein spikes that develop on the surface of cells exposed to the Oxford-AstraZeneca vaccine to the protein spike of the SARS-CoV-19 coronavirus.

• share
• favorite_border

• share
• favorite_border

Researchers at Michigan Medicine are helping lead the first national study of how highly allergic people react to mRNA COVID-19 vaccines. The trial, co-led by a U-M immunologist, will cover over 3,000 participants receiving the Pfizer and Moderna vaccines at up to 35 academic allergy research centers across the United States.

• share
• favorite_border

Nursing mothers who receive a COVID-19 vaccine may pass protective antibodies to their babies through breast milk for at least 80 days following vaccination, suggests new research from Washington University School of Medicine in St. Louis.

• share
• favorite_border

• Most patients with kidney failure who were undergoing hemodialysis developed a positive antibody response after being vaccinated for COVID-19, but their response was lower than that of individuals without kidney disease.

• share
• favorite_border

Researchers in the Oregon State University College of Science have taken a key step toward new drugs and vaccines for combating COVID-19 with a deep dive into one protein's interactions with SARS-CoV-2 genetic material.

• share
• favorite_border

• share
• favorite_border

SEATTLE —  April 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. April is National Minority Health Month, with a focus on the disproportionate impacts of COVID-19 on communities of color. See more details below on related Fred Hutch programming.Save the date for our monthly public science event, “Science Says” on Tuesday, April 27.

• share
• favorite_border

A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai study published today by the journal Nature Medicine.

• share
• favorite_border

Women who were vaccinated for COVID-19 earlier in their third trimester had a higher likelihood of passing protective antibodies to their newborn babies than women who received their vaccination closer to delivery, a new study from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has found.

• share
• favorite_border

Fewer than half of inmates in jails and prisons surveyed in a study by the CDC and University of Washington said they would accept a COVID-19 vaccine, while the majority either said they wanted to wait before getting the vaccine or would refuse one.

• share
• favorite_border

UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.

• share
• favorite_border

Among the nation’s largest providers of monoclonal antibodies for Covid-19, Houston Methodist has infused nearly 4,000 patients. The hospital system was able to quickly ramp up its program by leveraging numerous resources through interdisciplinary collaboration. A commentary outlining challenges, resources and benchmarks published online March 29 in the New England Journal of Medicine and serves as a valuable model as more hospitals begin to treat Covid-19 with mAB therapy.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19

• share
• favorite_border

Houston Methodist infectious disease pathologists have discovered new COVID-19 cases caused by the SARS-CoV-2 UK B.1.1.7 variant are doubling weekly. By mid-March the number increased sharply to 648 cases from 305 just a week earlier. The findings come from the latest batch of 8,857 virus genomes sequenced from patients with positive COVID-19 tests in the first two months of 2021, representing 94% of Houston Methodist cases.

• share
• favorite_border

More and more Americans are becoming vaccinated against COVID-19, but headlines warn that the number of cases is rising. What’s up with that?

• share
• favorite_border

• share
• favorite_border

FAU's Joanna Drowos, D.O., M.P.H., M.B.A., provides answers to some of the most frequently asked questions regarding COVID-19 vaccines.

• share
• favorite_border

An article launched today by the Forum of International Respiratory Societies (FIRS), an organization comprised of the world's leading international respiratory societies, including the American Thoracic Society, highlights COVID-19 efficacy and safety and calls for urgent equitable access in all countries.

• share
• favorite_border

More than a quarter of all U.S. parents say they do not intend to vaccinate their children against COVID-19, according to preliminary results from a study by Indiana University researchers.

• share
• favorite_border

During the 2020-2021 fall semester, school districts around the United States navigated their reopening plans with little data on how SARS-CoV-2 spreads among children or how in-person learning would impact transmission in the schools’ communities. A new study in The Journal of School Health joins a growing body of evidence that, with appropriate measures, there are ways for schools to safely reopen.

• share
• favorite_border

February 18, 2021 – King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Chula Faculty of Medicine, and Chula Vaccine Research Center (Chula VRC) jointly held a press conference on “The latest development on ChulaCov19 vaccine and its readiness for clinical trial”. On the panel were H.E. Anutin Charnvirakul, Deputy Prime Minister and Public Health Minister; Dr. Nakorn Premsri, the Director of National Vaccine Institute (NVI); Prof.Dr. Suttipong Wacharasindhu, Director of King Chulalongkorn Memorial Hospital, The Thai Red Cross Society and Dean of Chula Faculty of Medicine; and Dr.Kiat Ruxrungtham, Director of Chula Vaccine Research Center (Chula VRC). The event was moderated by Assoc. Prof. Dr. Jiruth Sriratanaban, Deputy Director of King Chulalongkorn Memorial Hospital.

• share
• favorite_border

Researchers will study vaccinated and non-vaccinated health workers who get tested for the virus after experiencing common COVID-19 symptoms like fever, cough or a loss of sense of taste or smell. They will compare the incidence of positive tests and severity of illness in those who test positive.

• share
• favorite_border

The foremost network of cancer centers in the United States is recommending that people wait to get certain imaging such as mammograms until four to six weeks after their final dose of their coronavirus vaccine — as long as the delay does not interfere with their health care.

• share
• favorite_border

An international team of researchers led by a University of Virginia School of Medicine professor is warning that scientists must better prepare for the next pandemic – and has developed a plan to do just that.

• share
• favorite_border

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses.

• share
• favorite_border

A team of UTEP faculty, staff and students observed several of El Paso’s drive-though and walk-in clinics in early 2021. The team identified areas that likely created bottlenecks, which produce delays and other issues. They used the information from their observations to develop simulation models to experiment with a clinic’s performance to further identify potential slowdowns, calculate resource utilization and reduce patient waiting time.

• share
• favorite_border

A new CoVPN study evaluating SARS-CoV-2 infection and transmission among college students vaccinated with the Moderna COVID-19 vaccine was announced today. The new trial will tell us whether a person can become infected after they’ve been vaccinated and if the vaccine will stop the virus from spreading person-to-person.

• share
• favorite_border

Although demand for COVID-19 vaccines currently seems high, vaccine hesitancy could pose a major threat to public health efforts to end the pandemic, according to an editorial published today in the journal Science.

• share
• favorite_border

As millions of people pack airports and planes over spring break at a time when only 25 percent of the population has received at least one COVID-19 vaccination, Lewis Nelson, director of the Department of Emergency Medicine at Rutgers New Jersey Medical School, says public health measures while traveling like social distancing, washing hands and mask wearing are still critical to remaining healthy and stopping the spread.

• share
• favorite_border

Irvine, Calif., March 24, 2021 – Vaccines are here, but as COVID-19 cases continue and variants spread, researchers need easy access to a wide variety of data to better understand the disease. Led by the University of California, Irvine, UC hospitals have received a $500,000 grant from the National Institutes of Health to make this possible.

• share
• favorite_border

Researchers at the Pritzker School of Molecular Engineering at the University of Chicago have developed a new therapeutic vaccine that uses a patient’s own tumor cells to train their immune system to find and kill cancer.

• share
• favorite_border

One year ago, then 65-year-old Miriam Clark developed a fever, lost her appetite and had no energy. She and her daughter, Tye Clark, the administrative services manager of the Johns Hopkins University School of Medicine Division of Hospital Medicine, never could have imagined what they would end up going through before Miriam was diagnosed with COVID-19. Looking back on the year, the mother and daughter duo are thankful and now even have reason to celebrate.

• share
• favorite_border

Ahead of the first U.S. emergency use authorization for a COVID-19 vaccine, only half of Americans said they were likely to get vaccinated as soon as possible.

• share
• favorite_border

As COVID-19 vaccines slowly roll out across the world, government officials in densely populated countries must still manage vulnerable communities at highest risk of an outbreak. In a new study published in the journal Risk Analysis, researchers in India propose a COVID Risk Assessment and Mapping (CRAM) framework that results in a zoned map that officials can use to place more targeted restrictions on high-risk communities. Successfully used by officials in Jaipur at the peak of the pandemic last spring, their framework could help other vulnerable countries avoid a shutdown of their regional economies.

• share
• favorite_border

A COVID-19 vaccine that could provide protection against both existing and future strains of the COVID-19 virus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.

• share
• favorite_border

People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study. And those who did test positive for COVID-19 had fewer complications if they received their flu shot.

• share
• favorite_border

The Foundation for Opioid Response Efforts (FORE) and the Addiction Policy Forum (APF) are launching a program to assist people with substance use disorder obtain COVID-19 vaccinations.

• share
• favorite_border

Wistar is pleased to announce the appointment of Richard M. Horowitz as chair of its Board of Trustees.